Titian Software (“Titian”), a market leader in life sciences sample management software, has announced that Griffith University’s Compounds Australia, Australia’s only dedicated compound management facility, has selected Titian’s Mosaic Sample Management platform (“Mosaic”) to manage their extensive compound collection and support future growth. Mosaic will enable optimisation of workflow efficiencies at Compounds Australia, underpinning the facility’s strategic growth to meet the needs of a growing drug discovery sector. 

Compounds Australia plays a critical role in advancing drug discovery, managing a diverse collection of over 1.5 million samples and supporting approximately 50 member organisations worldwide. The academic facility provides researchers access to high-value compound libraries as well as the specialist expertise and infrastructure required to screen those libraries in high throughput.

Following year-on-year growth since its establishment in 2007, Compounds Australia had outgrown its in-house sample management software. Recognising the need for a more scalable solution, they selected Titian, a market leader in sample management with 25 years of expertise, to help future-proof their operations.

Laboratory integrations are a leading factor in Compounds Australia’s adoption of Titian’s Mosaic platform. Compounds Australia will integrate their existing Hamilton Verso and Q series stores along with the Azenta SampleStore™ solutions using Mosaic’s off the shelf integrations. To further enhance data flow and automation of their sample handling processes, Mosaic will also be integrated to fulfilment platforms including HighRes Biosolutions® platform, Beckman Coulter Access™, and in the near future ThermoFisher Scientific Momentum™ system. This will optimise efficiency, minimize risks, reduce manual interventions and free up valuable resources.

Dr Nyssa Drinkwater, Manager at Compounds Australia, expressed her enthusiasm for the new partnership: “Titian has an excellent understanding of our business and clients’ needs in sample management. Sample management is at the core of Titian's business, and the Mosaic platform – customised to our needs by industry experts – will position us well for future growth and allow us to support an expanding client base. I am excited to start this partnership with Titian.” 

Rebecca Lang, Compounds Australia Operations Manager said: “Meeting the wide diversity of our clients’ needs has always been critical to Compounds Australia’s operations. Mosaic's modular design will enable us to maintain that flexibility without an extensive development time, allowing us to rapidly implement the platform and scale-up our services to drive more research forward.”

Angela Gray, Vice President of North and South America Sales at Titian, emphasised the importance of the project: “Compounds Australia is a critical resource for drug discovery in the region. We are proud to be a part of their continued success and growth in the global research community.”

This partnership underscores Titian’s dedication to delivering best-in-class sample management solutions, ensuring organisations like Compounds Australia can achieve their goals and continue driving innovations in drug discovery.

About Titian Software

Titian Software is a leading provider of sample management software for life science applications. Trusted by pharmaceutical, biotechnology and research institutions worldwide, Titian offers software products and consultancy services that enhance the supply of samples – including small molecules, reagents, proteins, and tissues – to support vital research. Titian’s flagship platform, Mosaic, improves throughput, reduces error rates and drives cost efficiencies - helping laboratories optimise their operations and accelerate scientific discovery.

About Compounds Australia

Compounds Australia, housed within Griffith University’s Institute for Biomedicine and Glycomics in Queensland, provides cost-effective sample management and logistics across the drug discovery pipeline. The facility stores and manages a range of open- and closed- access compound collections, plates those collections into flexible assay-ready formats, and distributes them to research organisations around the world.

Based around a custom-designed suite of advanced robotics, Compounds Australia supports efficient early-stage drug discovery nationally and internationally. Their flexible, open access model of operations enables collaborative research, allowing teams from a diverse range of organisations to outsource compound management so they can focus on the research. 

Compounds Australia acknowledges the support provided from the Australian Cancer Research Foundation (ACRF), Therapeutic Innovation Australia (TIA), Griffith University, and the Australian Government through the Australian Research Council, whose contributions enabled purchase of Titian's Mosaic. TIA is supported by the Australian Government through the National Collaborative Research Infrastructure Strategy (NCRIS) program.

Recent news from Titian Software